The End-of-the-Road for Immunotherapies in GBM or New Opportunities for More Nuanced/aggressive Approaches? CheckMate 498
Published in Brain Cancer4 May 2022
IMO, more like CheckMate trials, GBM game over.
Pre clinical rodent data results looked good, but did not benefit the GBM patients.
https://www.practiceupdate.com/c/135377/67/12/?elsca1=emc_enews_weekinreview&elsca2=email&elsca3=practiceupdate_braincancer&elsca4=braincancer&elsca5=newsletter&rid=NDQ3MTgxOTYwMzc4S0&lid=20849606
Regards.
The End-of-the-Road for Immunotherapies in GBM CheckMate 498
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)